Becker's Healthcare June 27, 2024
Respiratory syncytial virus vaccinations are now recommended for all adults over age 75 and for high-risk adults between ages 60 and 74, the CDC announced June 26.
Previously, vaccination against RSV was only recommended for use in adults aged 60 years and older, per the CDC. The new recommendations replace the previous guidance.
The CDC update was made to prioritize individuals most at risk of severe illness from the virus and “to simplify RSV vaccine decision-making for clinicians and the public,” the agency wrote in its update.
“People 75 or older, or between 60-74 with certain chronic health conditions or living in a nursing home should get one...
Today's Sponsors
Today's Sponsor